464
Views
16
CrossRef citations to date
0
Altmetric
Urology: Review

Defining response and non-response to treatment in patients with overactive bladder: a systematic review

, , , &
Pages 509-526 | Accepted 04 Oct 2013, Published online: 25 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Dudley Robinson, Miriam O’Kane & Linda Cardozo. (2023) Adherence to Overactive Bladder Syndrome Treatments Recent Developments and Future Perspectives. International Journal of Women's Health 15, pages 799-811.
Read now
Lars Grenabo, Sender Herschorn, Steven A. Kaplan, Linda Cardozo, David Scholfield, Daniel Arumi, Martin Carlsson, Douglass Chapman & Fady Ntanios. (2017) Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms. Current Medical Research and Opinion 33:10, pages 1731-1736.
Read now

Articles from other publishers (14)

Sylwester Michał Ciećwież, Klaudyna Lewandowska, Agnieszka Boroń, Jacek Brodowski, Jacek Kociszewski, Jeremy Simon Clark & Andrzej Ciechanowicz. (2022) Functional Polymorphism in the ADRB3 Gene, Encoding the Beta-3 Adrenergic Receptor, and Response to Intra-Detrusor Injection of Botulinum Toxin-A in Women with Overactive Bladder. Journal of Clinical Medicine 11:24, pages 7491.
Crossref
Evgenyi I. Kreydin, Cristiano M. Gomes & Francisco Cruz. (2021) Current pharmacotherapy of overactive bladder. International braz j urol 47:6, pages 1091-1107.
Crossref
Charan S. Mohan, Wai Lee & Kathleen C. Kobashi. (2021) Overactive Bladder: Where We Are and Where We Are Going. Société Internationale d’Urologie Journal:5, pages 311-322.
Crossref
X. Gamé & V. Phé. (2020) Traitement du syndrome clinique d’hyperactivité vésicale non neurologique réfractaire. Progrès en Urologie 30:14, pages 920-930.
Crossref
V. Phé & X. Gamé. (2020) Suivi et évaluation des traitements du syndrome clinique d’hyperactivité vésicale non neurologique. Progrès en Urologie 30:14, pages 931-937.
Crossref
Bárbara Padilla-Fernández & David M. Castro-Díaz. (2019) Combination Therapy for Overactive Bladder: Should We Define Refractoriness?. European Urology 76:6, pages 780-781.
Crossref
Aneta Obloza, Roderick Teo, Emily Marriott, Gillian Parker & Douglas Tincello. (2018) Association of baseline severity of lower urinary tract symptoms with the success conservative therapy for urinary incontinence in women. International Urogynecology Journal 30:5, pages 705-710.
Crossref
Nidhi Sharma & Sudakshina Chakrabarti. 2018. Pelvic Floor Disorders. Pelvic Floor Disorders.
Carsten Leue, Joanna Kruimel, Desiree Vrijens, Adrian Masclee, Jim van Os & Gommert van Koeveringe. (2016) Functional urological disorders: a sensitized defence response in the bladder–gut–brain axis. Nature Reviews Urology 14:3, pages 153-163.
Crossref
Jean-Jacques Wyndaele. (2016) The management of neurogenic lower urinary tract dysfunction after spinal cord injury. Nature Reviews Urology 13:12, pages 705-714.
Crossref
Christopher R. Chapple, Con J. Kelleher, Chris J. Evans, Zoe Kopp, Emad Siddiqui, Nathan Johnson & Morgan Mako. (2016) A Narrative Review of Patient-reported Outcomes in Overactive Bladder: What is the Way of the Future?. European Urology 70:5, pages 799-805.
Crossref
Vik Khullar, Gerard Amarenco, Javier C. Angulo, Mary Beth Blauwet, Jameel Nazir, Isaac A. Odeyemi & Zalmai Hakimi. (2015) Patient‐reported outcomes with the β 3 ‐adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder . Neurourology and Urodynamics 35:8, pages 987-994.
Crossref
Ulrich Schwantes, Joachim Grosse & Andreas Wiedemann. (2015) Refractory overactive bladder: a common problem?. International Urogynecology Journal 26:10, pages 1407-1414.
Crossref
Bassem S. Wadie. (2014) Management of Refractory OAB in the Non-Neurogenic Patient. Current Urology Reports 15:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.